by Alison Bass | Jan 21, 2009 | Uncategorized
It’s good to see that our new President is eager to fund the installation of an ambitious electronic medical records system that links doctors and hospitals with patient records, according to The New York Times. But as a number of legislators and consumers...
by Alison Bass | Jan 15, 2009 | Uncategorized
We’ve all heard the ominous reports about newspapers: as their print advertising disappears under the double whammy of the Internet (craiglist etc) and the recession, metropolitan newspapers are being forced to downsize, lay off veteran writers and cut back on...
by Alison Bass | Jan 8, 2009 | Uncategorized
I came back from vacation this week only to be greeted with bad news: Pharmalot, Ed Silverman’s blog on the pharmaceutical industry, is no more. How disappointing! The demise of Pharmalot not only creates a big hole in coverage — for me and many other...
by Alison Bass | Dec 28, 2008 | Uncategorized
Three days before Christmas, Emory University gave its long-time chief of psychiatry a nice holiday gift: in return for his stepping down as psychiatry head, university officials are allowing Charles Nemeroff to stay at the university as a full professor despite his...
by Alison Bass | Dec 18, 2008 | Uncategorized
I’m delighted to see that The New York Times has discovered the problem of ghostwriting — wherein drug companies pay shills to write medical journal articles and then go hunting for respected doctors to put their names on already prepared articles. And I...
by Alison Bass | Dec 11, 2008 | Uncategorized
Kudos to The Boston Globe for revealing a big loophole in Massachusetts’ new disclosure rules for health professionals: doctors who receive lucrative consulting and research funding from drug companies do not need to disclose these payments under the proposed...
